Researchers
at Allele Biotech achieved reprogramming of human fibroblasts into
iPSCs within one week, at “bulk conversion”, and with cells seeded at a
much wider density range compared to our previous publications.
These significant improvements will further facilitate high
throughput, large scale iPSC production using Allele’s feeder-free,
xeno-free, footprint-free
reprogramming, which was already a preferred method for both clinical
applications and stem cell banking. The reprogramming project is
currently being funded by the NIDA/NIH.
Sunday, August 4, 2013
Picture Blog: More Efficient Reprogramming for Creating Induced Stem Cells (iPSCs)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment